Discrimination of single-point mutations in unamplified genomic DNA via Cas9 immobilized on a graphene field-effect transistor.
Sarah BalderstonJeffrey J TaulbeeElizabeth CelayaKandace FungAmanda JiaoKasey SmithReza HajianGiedrius GasiunasSimonas KutanovasDaehwan KimJonathan ParkinsonKenneth DickersonJuan-José RipollRegis PeytaviHsiang-Wei LuFrancie BarronBrett R GoldsmithPhilip G CollinsIrina M ConboyVirginijus SiksnysKiana AranPublished in: Nature biomedical engineering (2021)
Simple and fast methods for the detection of target genes with single-nucleotide specificity could open up genetic research and diagnostics beyond laboratory settings. We recently reported a biosensor for the electronic detection of unamplified target genes using liquid-gated graphene field-effect transistors employing an RNA-guided catalytically deactivated CRISPR-associated protein 9 (Cas9) anchored to a graphene monolayer. Here, using unamplified genomic samples from patients and by measuring multiple types of electrical response, we show that the biosensors can discriminate within one hour between wild-type and homozygous mutant alleles differing by a single nucleotide. We also show that biosensors using a guide RNA-Cas9 orthologue complex targeting genes within the protospacer-adjacent motif discriminated between homozygous and heterozygous DNA samples from patients with sickle cell disease, and that the biosensors can also be used to rapidly screen for guide RNA-Cas9 complexes that maximize gene-targeting efficiency.
Keyphrases
- crispr cas
- genome wide
- genome editing
- end stage renal disease
- newly diagnosed
- ejection fraction
- copy number
- wild type
- chronic kidney disease
- dna methylation
- prognostic factors
- peritoneal dialysis
- blood pressure
- genome wide identification
- gold nanoparticles
- cell free
- minimally invasive
- gene expression
- carbon nanotubes
- transcription factor
- high throughput
- single cell